Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. ANI Pharmaceuticals, Inc.
483
•ANI Pharmaceuticals, Inc.•December 2, 2024

ANI Pharmaceuticals, Inc. – FDA 483, Dec 2, 2024

Record Details

The FDA conducted an inspection of ANI Pharmaceuticals Inc., located at 210 Main St, West, Baudette, MN, from December 2 to December 6, 2024. The inspection revealed several critical observations related to the company's drug manufacturing practices.

Key violations included inadequate cleaning of equipment, specifically the Fluid Bed Dryer, which showed contamination with Propafenone Hydrochloride, potentially affecting product safety and quality. Additionally, the firm failed to verify the identity of each drug component using specific tests, particularly for raw materials like Glycerin and Propylene Glycol, which are crucial for ensuring product integrity.

The inspection also noted that written procedures for equipment cleaning and maintenance were not consistently followed, as evidenced by powder build-up in mixing rooms. Furthermore, ANI Pharmaceuticals lacked proper supplier qualification processes, particularly for Thyroid API suppliers, which could compromise the quality of Thyroid Tablets released to the market.

The FDA requires ANI Pharmaceuticals to address these issues by implementing corrective actions, such as enhancing cleaning protocols, establishing robust identity verification processes for raw materials, ensuring adherence to written procedures, and completing supplier qualifications with signed quality agreements. These actions are necessary to comply with regulatory standards and ensure the safety and efficacy of their drug products.

Company
ANI Pharmaceuticals, Inc.
Inspection date
December 2, 2024
Product type
Drugs
Office
Minneapolis District Office
People
  • Lori B. Wikstrom
  • Elizabeth R. Bloom
  • Nibin Varghese
View Company Profile

ID · eb76a7e1-b1bf-4c66-903c-3075b16adf78

Other documents for ANI Pharmaceuticals, Inc.
  • 483 - 2022-11-18November 18, 2022
  • EIR - 2022-11-18November 18, 2022
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ANI Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.